CBIO
Catalyst Biosciences Inc
CEO
Nassim Usman
Employees
35
Industry
Pharmaceutical Preparation Manufacturing
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Loading...
Open
0.57
Mkt cap
19M
Volume
461K
High
0.58
P/E Ratio
-0.02
52-wk high
8.69
Low
0.48
Div yield
N/A
52-wk low
0.19

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.